ELECTROSURGICAL DEVICES MARKET ANALYSIS

Market Size and Trends

The electrosurgical devices market is estimated to be valued at USD 6.58 Bn in 2024 and is expected to reach USD 10.07 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.3% from 2024 to 2031.

To learn more about this report, request a free sample copy

The demand for electrosurgical devices is expected to grow steadily over the forecast period. Technological advancements aimed at making electrosurgery safer and effective are expanding the scope of procedures where electrosurgery devices are applicable. Manufacturers are focusing on developing single-use variants and devices with advanced features like adjustable power settings and improved insulation. Adoption of electrosurgical devices is being driven by an aging population undergoing increasing number of surgical procedures. Further, ambulatory surgery centers are gaining prominence which is supplementing the market growth of electrosurgery devices.

Increasing prevalence of chronic diseases

With the rising prevalence of chronic diseases globally, the number of surgical procedures has significantly increased over the past couple of decades. Chronic conditions such as cancer, cardiovascular diseases, and neurological disorders are some of the major public health issues contributing to the growing disease burden. According to the World Health Organization (WHO), cancer is the second leading cause of deaths worldwide with nearly 10 million deaths in 2020. Rising geriatric population is another key factor influencing the cancer statistics as older adults are more prone to develop cancer. Similarly, heart diseases also pose a huge economic and health burden on economies. Improved diagnostic capabilities and lifestyle changes have led to a surge in the number of open-heart surgeries and other cardiac procedures performed annually. Neurological disorders including Alzheimer's, Parkinson's, and stroke have enormous social and financial impacts. The growing number of such procedures along with the higher precision and control provided by advanced electrosurgery devices are propelling their demand across hospitals and Ambulatory Surgical Centers.

Market Concentration and Competitive Landscape

To learn more about this report, request a free sample copy

Over the past few decades, remarkable innovations have been witnessed in electrosurgical technologies aimed at making procedures safer, minimally-invasive, and more effective. Gradually moving from traditional monopolar and bipolar devices, advanced energy platforms such as Argon plasma coagulation, ultrasound, and vessel sealing systems are gaining momentum. These new age devices provide enhanced visibility, precision cutting, and hemostasis with reduced risk of collateral tissue damage. Manufacturers are constantly striving to develop intelligent systems with advanced bipolar and monopolar modes, automatic control of energy delivery and improved ergonomics. The integration of robotics, 3D imaging, tissue analytics, and newer energy modalities in electrosurgery intends for maximizing clinical outcomes.

To learn more about this report, request a free sample copy

The electrosurgical devices market faces several challenges. Strict regulatory frameworks and lengthy approval processes have increased the barriers to entry. Moreover, the need for continued investments in R&D to drive innovation pose financial burdens. Healthcare reforms in several countries have reduced reimbursements to hospitals and ambulatory surgery centers. This has restricted their spending power and affected demand for such high-cost capital equipment. Another major challenge is the presence of alternative treatment options like laser surgeries that offer similar clinical results.

Market Opportunities: Increasing demand for minimally invasive procedures

The rapidly aging global population susceptible to various medical conditions will drive surgical volumes. Moreover, the demand for minimally invasive procedures is growing with advancing technology. This is increasing the acceptance of electrosurgical equipment. There is also scope to expand in emerging markets as their healthcare infrastructure and accessibility improves. Adoption of distribution partnerships and strategic mergers by key market players is further anticipated to create lucrative opportunities for market development over the projected period.

To learn more about this report, request a free sample copy

The product type segment includes electrosurgical instruments, active electrodes, electrosurgical generators, and accessories. The electrosurgical generators segment is anticipated to hold 31.8% of the market share in 2024. Electrosurgical generators are computer-controlled power units that provide radiofrequency electrical current to electrosurgical devices, enabling both monopolar and bipolar electrosurgery. They serve as the central power source needed to conduct any electrosurgical procedure, controlling critical factors such as voltage, current, waveform, and duty cycle. This precise modulation of electrical energy allows surgeons to blend cutting and coagulation effects for optimal tissue effects. Generators enable gentle tissue cutting with sharp borders and reliable hemostasis, minimizing blood loss and postoperative complications. Their computerized controls give surgeons pinpoint precision over each stage of an operation. This level of control is a key driver of generator usage, as it increases surgical accuracy, efficiency and safety compared to older electrosurgery methods.

Insights, By Application: Rising Prevalence of Neurological Disorders

The application segment includes general surgery, gynecology, cardiology, neurology, dermatology, orthopedic surgery, and others. Neurology contributes the highest share of the electrosurgical devices market and is projected to hold 25.6% of the market share in 2024. Neurological surgery often requires both delicate tissue handling and precision hemostasis to avoid complications. Electrosurgery addresses both needs through technological advancements. New electrosurgical generators and instruments deliver micro-currents, allowing for remarkably fine tissue effects via minimal thermal spread. Simultaneous cutting and coagulation also help reduce operative blood loss which can obscure visibility in the highly specialized cranial field. Bipolar coagulation is especially important for hemostasis of cerebral cortexes and venous sinuses. Rising numbers of tumor resections, awake brain surgeries, and minimally invasive endoscopic procedures for conditions like hydrocephalus and epilepsy also fuel neurosurgical electrosurgery demand. As the aging population drives increased incidence of neurodegenerative diseases, electrosurgery innovation will continue enabling less invasive interventions for improved patient outcomes.

Insights, By End User: High footfall in hospitals for surgeries

The end user segment includes hospitals, specialty clinics, ambulatory surgical centers, and others. Hospitals contribute the highest share of the electrosurgical devices market and is projected to hold 39.6% of the market share in 2024. Hospitals cater to a large patient pool and conduct a wide range of surgeries requiring electrosurgical equipment. As the world population ages and lifestyle diseases increase, there is a growing burden of chronic and complex conditions that often require surgical interventions. Even relatively common procedures such as hernia and gallbladder removal account for millions of surgeries annually performed in hospitals. The availability of state-of-the-art operation theatres, high tolerance for technology, and well-trained medical staff allow hospitals to perform complex operations effectively with electrosurgical devices. These devices offer high precision and control over bleedings compared to conventional surgical methods. They help reduce surgical time, lower post-operative complications, and boost recovery. This has raised their adoption across major surgical specialties in hospitals.

Regional Insights

To learn more about this report, request a free sample copy

North America has been the dominant regional market for electrosurgical devices over the past few years and is projected to hold 42.9% of the market share in 2024. The large size of the U.S. healthcare market and the presence of well-established medical device players have supported market growth. Some of the key factors driving demand include the rise in surgical procedures, favorable reimbursement policies, technology advancements, and growing focus on minimally invasive surgeries. The availability of advanced medical infrastructure and growing adoption of innovative electrosurgical systems among medical practitioners have further augmented the North America market.

Asia Pacific has emerged as the fastest growing regional market for electrosurgical devices in recent years. Rapid economic development, growing medical tourism, rising healthcare expenditures, and increasing patient pool have shaped the growth dynamics of Asia Pacific countries. China and India are two of the most attractive markets, driven by their huge population sizes, unmet medical needs, and progress in healthcare infrastructure and facilities. At the same time, many nations in Asia Pacific still have a large proportion of disposable income spent on medical costs, indicating further scope for market expansion. This has benefited both global and local electrosurgical device manufacturers. The growing expertise of healthcare professionals and incorporation of advanced devices in hospitals and clinics are augmenting demand for electrosurgical devices.

Market Report Scope

Key Developments

• On January 24, 2024, Olympus Corporation, a global medical technology business, announced the full market availability of its new ESG-410 Surgical Energy Platform for conventional monopolar and bipolar, advanced energy applications such as ultrasonic dissection, and hybrid energy. The ESG-410 Surgical Energy Platform provides a comprehensive energy solution with applications in a variety of disciplines, including general surgery, thoracic surgery, urology, and gynecology.
• In April 2023, Innoblative Designs, Inc., a private medical device company that addresses clinical unmet needs for breast cancer patients, announced that its SIRA RFA Electrosurgical Device (SIRA) has been designated as a Breakthrough Device by the U.S. Food and Drug Administration (FDA). The SIRA device is intended for use in breast cancer patients undergoing BCS, often known as lumpectomy.
• In October 2022, ZEISS Medical Technology, a healthcare technology company, announced that MTLawton has been granted 510(k) approval by the U.S. FDA. These new disposable bipolar forceps, composed of a unique copper-base alloy, have the potential to minimize tissue adhesion and consequent charring during tissue dissection. The forceps' longer shaft reduces sight limits in the surgical field, allowing surgeons to be more efficient during electrosurgical treatments.
• In September 2022, US Medical Innovations, LLC (USMI), a subsidiary of US Patent Innovations, LLC, a private biomedical technology firm, announced that it has secured a USD 10.2 million private placement agreement from a variety of sources, including current partners and new investors. USMI plans to use these funds to increase production of its recently announced Canady Plasma XL-1000 SMART Electrosurgical Generator (XL-1000), as well as to support the development and release of its Canady Helios Cold Plasma Generator (CHCP) and robotic delivery system for cancer therapy.

*Definition: The electrosurgical devices market comprises equipment used for surgical procedures that utilize high-frequency alternating current delivered via an electrode. Electrosurgical devices cover generators, electrodes, and accessories used for electrosurgery. Generators supply radiofrequency electrical current to perform techniques such as cutting, coagulation, desiccation, and fulguration in various open and minimally invasive surgical procedures across therapeutic areas like gastroenterology, gynecology, urology, and general surgery.

Market Segmentation

•  Product Type Insights (Revenue, USD BN, 2019 - 2031)
  • Electrosurgical Instruments
  • Active Electrodes
  • Electrosurgical Generators
  • Accessories
•  Application Insights (Revenue, USD BN, 2019 - 2031)
  • General surgery
  • Gynecology
  • Cardiology
  • Neurology
  • Dermatology
  • Orthopedic Surgery
  • Others
•  End User Insights (Revenue, USD BN, 2019 - 2031)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
• Regional Insights (Revenue, USD BN, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Bovie Medical Corporation
  • Medtronic Plc
  • BOWA-Electronic GmbH & Co. KG
  • KLS Martin
  • B. Braun Melsungen AG
  • Conmed
  • Olympus Corp.
  • Boston Scientific Corporation
  • Erbe Elektromedizin GmbH
  • Symmetry Surgical Inc.
  • Encision Inc.
  • Gala Therapeutics Inc.
  • Apyx Medical Corporation
  • Johnson & Johnson Services Inc.
  • Innoblative Designs
  • Stryker Corporation
  • Smith & Nephew PLC